Mental Health Clinics in Cleveland, OK Accepting Medicare
7 Mental Health Clinics found. Showing 1 - 7
 Grand Mental Health Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 907 W Caddo St, Cleveland, OK 74020 Phone: 918-308-5511 Fax: 918-205-2701 |
Grand Lake Mental Health Center, Inc. Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 901 W Caddo St, Cleveland, OK 74020 Phone: 918-308-5511 |
The Haven Mental Health And Wellness Pllc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 303 N Broadway St, Cleveland, OK 74020 Phone: 918-956-9014 Fax: 918-514-8893 |
Grand Mental Health Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 907 W Caddo St, Cleveland, OK 74020 Phone: 918-305-5511 Fax: 918-205-2701 |
Grand Lake Mental Health Center, Inc. Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 907 W Caddo St, Cleveland, OK 74020 Phone: 918-308-5511 Fax: 918-205-2701 |
Youthcare Of Oklahoma - Cleveland Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 600 N Gilbert Ave, Cleveland, OK 74020 Phone: 918-289-0550 |
Keystone Counseling And Therapeutic Services Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 907 W Caddo St, Cleveland, OK 74020 Phone: 918-358-5339 Fax: 918-358-5385 |
News Archive
Drug that makes the failing heart heal itself
Researchers have found that a drug can heal heart muscles in mice. Earlier it was considered that this damage to the heart is permanent but this new findings refutes earlier beliefs.
Inhibiting SARS-CoV-2 cell entry with monoclonal antibodies against staphylococcal enterotoxin B superantigen
In a recent cutting-edge study, US researchers unveiled an anti-staphylococcal enterotoxin B monoclonal antibody that can be repurposed to target the cleavage site of the SARS-CoV-2 spike glycoprotein and, in turn, inhibit viral infection. Their findings are currently available on bioRxiv preprint server.
Colon Cancer Alliance's statement regarding a new report on drop in colorectal cancer
A recent study by the Centers for Disease Control and Prevention (CDC), American Cancer Society (ACS), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR) highlighting that the death rate from colorectal cancer over the last decade dropped nearly 20 percent and that by 2020 could be cut in half is welcomed news.
FDA announces required class-wide safety labeling changes for IR opioid pain medications
In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration today announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications. Among the changes, the FDA is requiring a new boxed warning about the serious risks of misuse, abuse, addiction, overdose and death.
ImmunoCellular Therapeutics announces long-term data from ICT-107 Phase I clinical trial for GBM
ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced long-term data from a Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.
› Verified 5 days ago